Neuronascent Granted Third US Patent for Potential Methods to Treat Alzheimer’s, Other Disorders

Neuronascent Granted Third US Patent for Potential Methods to Treat Alzheimer’s, Other Disorders
Neuronascent has been issued a U.S. patent for methods of stimulating neurogenesis and/or inhibiting neuronal degeneration that have potential therapeutic applications in Alzheimer’s disease, Parkinson’s disease, post-traumatic stress disorder, depression, and other psychiatric disorders. The biopharma Neuronascent discovers and develops novel therapeutics aimed at halting or reversing neurological disorders. The new patent (No. 9,539,261) expands the company’s

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *